🇺🇸 FDA
Patent

US 7888121

Methods and compositions for targeted cleavage and recombination

granted A61KA61K2035/124A61K35/12

Quick answer

US patent 7888121 (Methods and compositions for targeted cleavage and recombination) held by Sangamo Biosciences, Inc. expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K2035/124, A61K35/12